
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1089 | 1075 | 1127 | 1078 | 1326 | 2275 |
Fund Return | 8.9% | 7.46% | 12.73% | 2.54% | 5.8% | 8.57% |
Place in category | 42 | 71 | 435 | 234 | 114 | 18 |
% in Category | 5 | 11 | 64 | 42 | 25 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquZD | 2.29B | 10.09 | 3.81 | 7.80 | ||
Pictet CH Institutional Swiss EquiI | 2.29B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquiP | 2.29B | 8.84 | 1.85 | 7.84 | ||
Pictet CH Institutional Swiss EquID | 2.29B | 4.62 | -3.37 | 6.34 | ||
Pictet CH Institutional Swiss EquPD | 2.29B | 4.41 | -3.57 | 6.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.73B | 11.69 | 5.78 | 7.07 | ||
Pictet CH Institutional Swiss EquiI | 2.29B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquZD | 2.29B | 10.09 | 3.81 | 7.80 | ||
Pictet CH Institutional Swiss EquiP | 2.29B | 8.84 | 1.85 | 7.84 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.57B | 9.00 | 1.31 | 6.36 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 13.61 | 307.00 | +1.42% | |
Nestle | CH0038863350 | 11.52 | 89.72 | +2.12% | |
Novartis | CH0012005267 | 9.85 | 100.92 | +1.46% | |
ABB | CH0012221716 | 6.23 | 49.23 | +0.63% | |
Zurich Insurance Group | CH0011075394 | 5.61 | 594.80 | +0.44% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review